Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clarivate (CLVT) EBT (2018 - 2025)

Clarivate's EBT history spans 8 years, with the latest figure at -$24.6 million for Q4 2025.

  • For Q4 2025, EBT rose 81.39% year-over-year to -$24.6 million; the TTM value through Dec 2025 reached -$193.9 million, up 64.99%, while the annual FY2025 figure was -$193.9 million, 64.99% up from the prior year.
  • EBT reached -$24.6 million in Q4 2025 per CLVT's latest filing, roughly flat from -$24.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $245.6 million in Q4 2022 to a low of -$4.4 billion in Q3 2022.
  • Average EBT over 5 years is -$300.4 million, with a median of -$57.7 million recorded in 2021.
  • The largest YoY upside for EBT was 320.66% in 2022 against a maximum downside of 13786.6% in 2022.
  • A 5-year view of EBT shows it stood at -$111.3 million in 2021, then skyrocketed by 320.66% to $245.6 million in 2022, then plummeted by 450.94% to -$861.9 million in 2023, then skyrocketed by 84.66% to -$132.2 million in 2024, then surged by 81.39% to -$24.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLVT's EBT are -$24.6 million (Q4 2025), -$24.5 million (Q3 2025), and -$59.7 million (Q2 2025).